Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 128 Magnetic Resonance Spectroscopy 105 Biopsy 76 pembrolizumab 63 Nivolumab 60 Carboplatin 59 Cisplatin 57 Cyclophosphamide 53 Paclitaxel 44 Radiotherapy 36 Bevacizumab 36 Gemcitabine 34 Dexamethasone 33 Rituximab 26 Doxorubicin 26 olaparib 25 Pemetrexed 25 Fluorouracil 25 atezolizumab 24 Radiation 24 Injections 23 Docetaxel 23 fludarabine 22 durvalumab 22 Vincristine 21 Prednisone 21 Oxaliplatin 21 Ipilimumab 21 Cytarabine 21 venetoclax 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Heparin, Low-Molecular-Weight × 30 days × Clear all

NCT05498428 2026-06-05

PALOMA-2

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡